Millennium Pharmacon (Indonesia) Today

SDPC Stock  IDR 144.00  1.00  0.69%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Millennium Pharmacon is selling for 144.00 as of the 18th of March 2024. This is a -0.69 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 136.0. Millennium Pharmacon has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Millennium Pharmacon International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of February 2024 and ending today, the 18th of March 2024. Click here to learn more.
PT Millennium Pharmacon International Tbk distributes and trades in prescription medicine, non-prescription medicine, food supplements, and medical devices. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. The company has 1.27 B outstanding shares. More on Millennium Pharmacon International

Moving together with Millennium Stock

  0.63KBLV First Media TbkPairCorr
  0.67PALM Provident Agro TbkPairCorr
  0.73MDRN Modern Internasional TbkPairCorr

Moving against Millennium Stock

  0.73INDO Royalindo Investa WijayaPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Millennium Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Millennium Pharmacon's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Millennium Pharmacon or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President DirectorMohamad Mukhtar
Business ConcentrationHealth Care, Health Care Providers & Services, Medical Distribution, Healthcare (View all Sectors)
Millennium Pharmacon International (SDPC) is traded on Jakarta Exchange in Indonesia and employs 1,089 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 440.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Millennium Pharmacon's market, we take the total number of its shares issued and multiply it by Millennium Pharmacon's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Millennium Pharmacon operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 1.27 B outstanding shares. Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24.
Check Millennium Pharmacon Probability Of Bankruptcy
Ownership Allocation
Millennium Pharmacon maintains a total of 1.27 Billion outstanding shares. Millennium Pharmacon International secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 87.94 % of Millennium Pharmacon International outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Millennium Ownership Details

Millennium Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of Millennium Pharmacon jumping above the current price in 90 days from now is about 92.19%. The Millennium Pharmacon International probability density function shows the probability of Millennium Pharmacon stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Millennium Pharmacon International has a beta of -0.1868. This usually implies as returns on benchmark increase, returns on holding Millennium Pharmacon are expected to decrease at a much lower rate. During the bear market, however, Millennium Pharmacon International is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Millennium Pharmacon is significantly underperforming NYSE Composite.
  Odds Below 144.0HorizonTargetOdds Above 144.0
7.71%90 days
 144.00 
92.19%
Based on a normal probability distribution, the odds of Millennium Pharmacon to move above the current price in 90 days from now is about 92.19 (This Millennium Pharmacon International probability density function shows the probability of Millennium Stock to fall within a particular range of prices over 90 days) .

Millennium Pharmacon Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Millennium Pharmacon market risk premium is the additional return an investor will receive from holding Millennium Pharmacon long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Millennium Pharmacon. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Millennium Pharmacon's alpha and beta are two of the key measurements used to evaluate Millennium Pharmacon's performance over the market, the standard measures of volatility play an important role as well.

Millennium Stock Against Markets

Picking the right benchmark for Millennium Pharmacon stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Millennium Pharmacon stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Millennium Pharmacon is critical whether you are bullish or bearish towards Millennium Pharmacon International at a given time. Please also check how Millennium Pharmacon's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Millennium Pharmacon without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Millennium Pharmacon Corporate Management

Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mohamad HassanF DirectorProfile
ArisChairman AuditProfile
Dian AnggreniLegal and Corporate SecretaryProfile
Ernie HilalCorporate SecretaryProfile
Yungkis SucandraHead UnitProfile

How to buy Millennium Stock?

Before investing in Millennium Pharmacon, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Millennium Pharmacon. To buy Millennium Pharmacon stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Millennium Pharmacon. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Millennium Pharmacon stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Millennium Pharmacon International stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Millennium Pharmacon International stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Millennium Pharmacon International, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Millennium Pharmacon International?

The danger of trading Millennium Pharmacon International is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Millennium Pharmacon is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Millennium Pharmacon. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Millennium Pharmacon is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Millennium Stock analysis

When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Please note, there is a significant difference between Millennium Pharmacon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Millennium Pharmacon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Millennium Pharmacon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.